BiotechTube
Home/Nykode Therapeutics/Dr. John Beadle
DJ

Dr. John Beadle

Board Member

Nykode Therapeutics

Therapeutic Areas

OncologyAutoimmune DiseasesInfectious Diseases

Nykode Therapeutics Pipeline

DrugIndicationPhase
VB10.16Human papillomavirus type 16 (HPV16)-positive cancersPhase 2
VB10.NEOLocally advanced and metastatic tumorsPhase 1b

Leadership Team at Nykode Therapeutics

DB
Dr. Barbara Krebs-Pohl
Chair of the Board
SS
Susanne Stuffers
Board Member
CÅ
Christian Åbyholm
Board Member
TL
Trygve Lauvdal
Board Member
PB
Professor Bjarne Bogen
Scientific Founder (Technology originator)
PI
Professor Inger Sandlie
Scientific Founder (Contributor to technology development)
View full Nykode Therapeutics profile